Skip to main content
FDA Updates
FLAG-IDA Regimen-Induced Thrombotic Microangiopathy: A Case Report
Juan Montoro, MD, Montserrat Gomez, MD, Mar Tomo, MD PhD, Teresa Torrecillas, PhD
Read More
Original Research
Quantification of Weight Changes Associated with New Diagnosis of Cancer in Pediatric Patients
Misty M. Miller, PharmD, BCPS, Teresa V. Lewis, PharmD, BCPS, Ryan Webb, MPH, David A. Fields, PhD
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
FDA Updates
The Effect of Atazanavir on Doxorubicin Pharmacokinetics: A Case Report
Neha Umesh Sheth, PharmD, AAHIVP, BCPS, Steven Gilmore, PharmD, BCOP, Kenneth S. Bauer Jr, PharmD, PhD, Saranya Chumsri, MD
Read More
FDA Updates
Palifermin Use for the Prevention of Chemotherapy-Induced Oral Mucositis in Anal Cancer: A Case Report
Amanda Brahim, PharmD, BCPS, Mohammed Ibrahim, PharmD, CRPH, BCOP, BCPS, Tim Nguyen, MD, Zahava Ohana, PharmD
Read More
From the Literature
Rituximab Maintenance Prolongs Progression-Free Survival in Patients with Relapsed Follicular Lymphoma Undergoing High-Dose Chemotherapy and Autologous Transplantation
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature
Crizotinib Superior to Standard Chemotherapy in Patients with ALK-Positive Lung Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
From the Literature
Neoadjuvant Lapatinib and Trastuzumab with Hormonal Therapy and No Chemotherapy Beneficial in Patients with HER2 Breast Cancer
Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
Original Research
Pharmacist Assessment of Polypharmacy Risks in Patients with Cancer
Robert Mancini, PharmD, BCOP, FHOPA, Kathleen Clifford, MSN, FNP-BC, AOCNP, ACHPN
Read More
FDA Updates
Ipilimumab: Unique Responses, Toxicities, and Recommendations for the Use of the First Anti–CTLA-4 Therapy in Patients with Melanoma
Michael K.K. Wong, MD, PhD, FRCPC, Anthony Jarkowski III, PharmD, BCOP
Read More
Page 184 of 196
Results 1831 - 1840 of 1955